Skip to main content
v2026.11,858 entries · CC-BY 4.0
LAC HealthMedical & Research SuppliesReagents, PPE & instruments — chain-of-custody documented.Fast, traceable sourcing built for regulated research environments, from bench consumables to instrumentation.Shop lac.us CodeCASRAIlac.us

Centor Score, McIsaac Score, and FeverPAIN Score: Group A Strep Pharyngitis Prediction Rules, IDSA/NICE Guidelines, and Telehealth CDS

Compare the 4-item Centor Score, Age-Modified McIsaac Score (-1 to 5), and 5-item UK NICE FeverPAIN Score for acute streptococcal pharyngitis and RADT stewardship.

Written and maintained by CASRAI Editorial Board

Last updated

The Centor Score (Centor et al., 1981) and the Age-Modified Centor / McIsaac Score (McIsaac et al., 1998, 2004) are the primary clinical prediction rules used in outpatient clinics, emergency departments, and Clinical Quality Language (CQL) antimicrobial stewardship pathways to estimate the probability that an acute sore throat is caused by Group A β-hemolytic Streptococcus (GAS, Streptococcus pyogenes) rather than a respiratory virus. Because viral pharyngitis accounts for 70%–85% of acute sore throat visits in adults and 60%–70% in children, validated clinical scoring rules prevent both unnecessary Rapid Antigen Detection Testing (RADT) in low-risk viral cases and inappropriate empiric antibiotic prescribing.

In global primary care, Schmitt-Thompson telephone triage protocols, and telehealth nursing workflows, clinicians pair the Centor and McIsaac Scores with the 5-item UK NICE FeverPAIN Score (Little et al., 2013).

What Are the 4 Clinical Criteria of the Original Centor Score and the Age Adjustment (+1 for Age 3–14, -1 for Age ≥45) in the Modified Centor (McIsaac) Score?

In 1981, Robert M. Centor and colleagues derived a 4-variable logistic regression model in adult emergency room patients presenting with acute pharyngitis, assigning 1 point for each of 4 clinical findings (range 0 to 4 points). Because original Centor was derived only in adults (aged ≥15 years) and epidemiological prevalence of Group A Streptococcus peaks sharply in school-age children (5–15 years) while falling steeply after age 45, Warren J. McIsaac and colleagues (1998, 2004) added an age modifier that expands the score range from −1 to 5 points:

Criterion Category Clinical Variable (Centor 1981 / McIsaac 1998) Points
4 Core Centor Clinical Criteria
(0 to 4 points)
1. Tonsillar exudates or swelling (erythema/hypertrophy with purulent exudate on tonsils or pharynx) +1
2. Tender or swollen anterior cervical lymph nodes (anterior cervical lymphadenopathy) +1
3. History of fever (or measured oral temperature > 38.0°C / 100.4°F) +1
4. Absence of cough +1
McIsaac Age Modifier
(Total McIsaac range: −1 to 5 points)
• Age 3 to 14 years (highest pediatric GAS prevalence) +1
• Age 15 to 44 years 0
• Age ≥ 45 years (lowest adult GAS prevalence) −1

How Do IDSA and ACP/CDC Guidelines Use the McIsaac Score (-1 to 5) to Guide Rapid Antigen Detection Testing (RADT) and Antimicrobial Stewardship?

In the validation cohorts of McIsaac et al. (CMAJ 1998; JAMA 2004) and Fine et al. (Ann Intern Med 2012; 206,870 patients), the probability of a positive Group A Streptococcus throat culture or RADT rises monotonically across McIsaac score strata, governing diagnostic testing and antibiotic stewardship under the Infectious Diseases Society of America (IDSA 2012) and American College of Physicians / Centers for Disease Control and Prevention (ACP/CDC) guidelines:

McIsaac (Modified Centor) Score Empirical GAS Probability (McIsaac / Fine Cohorts) IDSA & ACP/CDC Diagnostic and Antimicrobial Stewardship Recommendation
Score −1 or 0 1% – 2.5% No RADT / No Culture / No Antibiotics: Risk of GAS is no higher than asymptomatic pharyngeal carriage. Provide symptomatic analgesia (NSAIDs/acetaminophen).
Score 1 5% – 10% No Routine Testing or Antibiotics: Neither RADT nor empiric antibiotic therapy is routinely indicated (unless recent documented household exposure to GAS or history of acute rheumatic fever).
Score 2 11% – 17% Perform Rapid Antigen Detection Test (RADT): Prescribe narrow-spectrum penicillin V or amoxicillin only if RADT (or backup throat culture in children/adolescents) is positive.
Score 3 28% – 35% Perform RADT: Treat with antibiotics if RADT is positive. (In children and adolescents aged 3–17 years with a negative RADT, IDSA mandates a backup throat culture due to higher pediatric risk of acute rheumatic fever; backup culture is not routinely required in adults after a negative RADT.)
Score 4 or 5 51% – 57% Perform RADT (IDSA Preferred) or Empiric Therapy: Because even a McIsaac score of 4–5 has a ~45% false-positive rate for viral pharyngitis, IDSA recommends confirming GAS with RADT before prescribing antibiotics, rather than treating empirically without testing.

Pediatric Exclusion (< 3 Years of Age): IDSA guidelines explicitly recommend against routine GAS testing in children under 3 years of age (unless an older sibling has confirmed GAS infection) because classic streptococcal pharyngitis and acute rheumatic fever are exceptionally rare in infants and toddlers.

How Does the UK NICE 5-Item FeverPAIN Score Compare with the McIsaac Score in Telehealth Sore-Throat Triage?

In the United Kingdom, where point-of-care RADT swabs are not routinely used in National Health Service (NHS) general practice, Paul Little and colleagues (PRISM Trial, BMJ 2013) developed the 5-item FeverPAIN Score, which is endorsed alongside Centor by UK NICE Guideline NG84 (Sore throat [acute]: antimicrobial prescribing):

  • F — Fever during the previous 24 hours (+1 point)
  • P — Purulence (pus on tonsils) (+1 point)
  • A — Attend rapidly (patient presents within ≤ 3 days after onset of symptoms) (+1 point)
  • I — Severely Inflamed tonsils (+1 point)
  • N — No cough or coryza (absence of both cough and runny nose/catarrh) (+1 point)

Under NICE NG84, a FeverPAIN score of 0 or 1 (13%–18% streptococcal probability; equivalent to Centor 0–2) warrants no antibiotic prescription; a FeverPAIN score of 2 or 3 (34%–40% probability) warrants either no antibiotic or a back-up (delayed) antibiotic prescription (instructing the patient to fill the script only if symptoms do not start to improve within 3–5 days or worsen significantly); and a FeverPAIN score of 4 or 5 (62%–65% probability; equivalent to Centor 3–4) warrants consideration of an immediate antibiotic prescription or point-of-care testing.

Telehealth Sore-Throat Triage Limitations & HEDIS CWP / FHIR CDS Integration

In synchronous video telemedicine and asynchronous e-visits:

  • Physical Exam Limitations in Telemedicine: While 3 of the 5 McIsaac items (age, fever history, absence of cough) and 3 of the 5 FeverPAIN items (fever in 24h, rapid attendance ≤3 days, absence of cough/coryza) can be captured reliably by patient history, anterior cervical lymph node palpation cannot be performed over video (unless approximated by patient self-palpation of tender neck glands), and smartphone throat photography has variable sensitivity for tonsillar exudates.
  • NCQA HEDIS Appropriate Testing for Pharyngitis (CWP) & FHIR CDS Hooks: Under the NCQA HEDIS CWP electronic clinical quality measure (eCQM) and HL7 FHIR Observation / CDS Hooks (`order-sign`), whenever a clinician orders an antibiotic for an ICD-10 diagnosis of acute pharyngitis or tonsillitis (J02.x, J03.x), the EHR calculates the McIsaac score and fires a hard-stop or soft-stop alert requiring a linked LOINC-coded Group A Streptococcus RADT or culture order before releasing the prescription.

Frequently Asked Questions

What are the 4 clinical criteria of the original Centor Score and the age adjustment (+1 for age 3–14, -1 for age ≥45) in the Modified Centor (McIsaac) Score?

The original Centor Score assigns 1 point each (0–4 points) for four clinical features: (1) tonsillar exudates or swelling, (2) tender or swollen anterior cervical lymph nodes, (3) history of fever (>38.0°C / 100.4°F), and (4) absence of cough. The Modified Centor (McIsaac) Score adds an age adjustment of +1 point for ages 3–14 years, 0 points for ages 15–44 years, and −1 point for ages ≥45 years, producing a total score from −1 to 5.

How do IDSA and ACP/CDC guidelines use the McIsaac Score (-1 to 5) to guide Rapid Antigen Detection Testing (RADT) and antimicrobial stewardship?

Under IDSA and ACP/CDC guidelines, patients with a McIsaac score of −1, 0, or 1 have a low probability of Group A Streptococcus (1%–10%) and should receive neither Rapid Antigen Detection Testing (RADT) nor antibiotics. Patients with a McIsaac score of 2, 3, or 4–5 should undergo RADT (with backup throat culture for negative RADTs in children and adolescents aged 3–17), and receive narrow-spectrum penicillin or amoxicillin only when testing confirms GAS.

How does the UK NICE 5-item FeverPAIN Score compare with the McIsaac Score in telehealth sore-throat triage?

The UK NICE 5-item FeverPAIN Score evaluates Fever in the past 24 hours, Purulence on tonsils, Attend rapidly (≤3 days), Severely Inflamed tonsils, and No cough or coryza (0–5 points), replacing cervical lymph node palpation (which cannot be performed directly over video telehealth) with symptom onset duration and coryza. NICE recommends no antibiotics for FeverPAIN 0–1, a delayed/back-up prescription for FeverPAIN 2–3, and immediate antibiotics or point-of-care testing for FeverPAIN 4–5.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Centor Score, McIsaac Score, and FeverPAIN Score: Group A Strep Pharyngitis Prediction Rules, IDSA/NICE Guidelines, and Telehealth CDS

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →